Beijing, China

Jirun Peng

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 832,843 
Other
 patents

Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jirun Peng: Innovator in Medicinal Chemistry

Introduction

Jirun Peng is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at combating tumor angiogenesis. His innovative work has the potential to impact cancer treatment significantly.

Latest Patents

Jirun Peng holds a patent for the "Use of phenethyl caffeate derivatives in the preparation of a medicament against tumor angiogenesis." This patent discloses the use of specific compounds represented by a defined formula in the creation of a medicament targeting tumor angiogenesis. The compounds include various groups and substitutions that enhance their efficacy in medical applications.

Career Highlights

Throughout his career, Jirun Peng has focused on the intersection of chemistry and medicine. His research has led to advancements in the understanding of how certain compounds can be utilized in therapeutic settings. His work is characterized by a commitment to innovation and a desire to improve patient outcomes.

Collaborations

Jirun has collaborated with esteemed colleagues, including Junyi Liu and Yansheng Du, who have contributed to his research endeavors. These collaborations have fostered a productive environment for innovation and discovery in medicinal chemistry.

Conclusion

Jirun Peng's contributions to the field of medicinal chemistry, particularly through his patent on phenethyl caffeate derivatives, highlight his role as an innovator in the fight against cancer. His work exemplifies the importance of research and collaboration in developing effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…